Talya Nevo-Hacohen - 28 Nov 2025 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Dec 2025, 15:22:45 UTC
Prior SEC filing
03 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Costa, as Attorney-in-Fact

Key filing fact

Talya Nevo-Hacohen filed Form 4 for Sabra Health Care REIT, Inc. (SBRA) on 02 Dec 2025.

Key facts

  • This page summarizes Talya Nevo-Hacohen's Form 4 filing for Sabra Health Care REIT, Inc. (SBRA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Dec 2025, 15:22.

Change

  • Previous filing in this sequence was filed on 03 Sep 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001505080 Primary reporting owner

Nevo-Hacohen Talya

Relationship
Executive VP, CIO & Treasurer
Address
C/O SABRA HEALTH CARE REIT, INC., 1781 FLIGHT WAY, TUSTIN
Signature
/s/ Michael Costa, as Attorney-in-Fact
Signature date
02 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SBRA transaction

Common Stock

Award

Transaction value
$0
Shares
+4,366
Change %
+1.3%
Price
$0.000000
Shares after
340,355
Date
28 Nov 2025
Ownership
Direct
Footnotes
F1, F2
SBRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
529,206
Date
28 Nov 2025
Ownership
By The Talya Nevo-Hacohen Trust
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

Footnote F2

Includes 288,325 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .